Psychiatric and cardiovascular comorbidities in patients with diabetes mellitus starting antiobesity drugs

Obesity
Marjolein J WillemenAntoine C Egberts

Abstract

The aim of the study was to assess whether the baseline risk of psychiatric and cardiovascular disease in patients with diabetes mellitus differs between those starting to use antiobesity drugs and those not starting to use these drugs. A retrospective nested case-control study within the General Practice Research Database (1987-2002) was done. The cohort included all patients with diabetes mellitus (n = 141,164). Information on patient characteristics (general, cardiovascular, and psychiatric characteristics) was extracted from the medical records. Crude odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. A total of 511 patients starting to use antiobesity drugs (cases) and 3,065 controls were included in the study cohort. Starters were younger and more frequently female. Of the starters, 91.8% did not receive any dietary advice before starting treatment. Depression (in the year before index date) was associated with the use of antiobesity drugs (OR 2.2; 95% CI 1.7-2.8), as was anxiety (OR 1.6; 95% CI 1.1-2.4). Of the cases, 25.2% had multiple cardiovascular risk factors (>4) compared to 19.0% of the controls. The baseline risk for psychiatric disorders and cardiovascular disease was found to be higher in pat...Continue Reading

References

Sep 10, 1998·The New England Journal of Medicine·H JickL E Derby
Oct 21, 1999·Journal of Public Health Medicine·R LawrensonR Farmer
May 14, 2003·Pharmacotherapy·Susan S JickHershel Jick
Sep 16, 2004·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Louise Wood, Carlos Martinez
Mar 30, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Lisa L Ioannides-DemosJohn J McNeil
Jun 1, 2006·The Annals of Pharmacotherapy·B Marianne VerdelHubert Gm Leufkens
Jul 1, 2006·Thorax·E M W van de GardeH G M Leufkens
Sep 7, 2007·Lancet·Martin PrinceAtif Rahman

❮ Previous
Next ❯

Citations

May 6, 2009·Pharmacoepidemiology and Drug Safety·Marjolein J C WillemenMiriam C J M Sturkenboom
Oct 16, 2012·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Marjolein J C WillemenToine C G Egberts

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

The Journal of Investigative Dermatology
Joel M GelfandAndrea B Troxel
Movement Disorders : Official Journal of the Movement Disorder Society
L Joseph MeltonWalter A Rocca
© 2022 Meta ULC. All rights reserved